Home/Bausch Health/Brett Shulman

BS

Brett Shulman

President, Solta Medical

Therapeutic Areas

Gastroenterology Dermatology/Aesthetics

Bausch Health Pipeline

Drug	Indication	Phase
XIFAXAN (rifaximin)	Pediatric Irritable Bowel Syndrome with Diarrhea (IBS-D)	Phase 3
Amiselimod	Moderate to Severe Ulcerative Colitis	Phase 2
Relamorelin	Diabetic Gastroparesis	Phase 2

Leadership Team at Bausch Health

Thomas J. Appio

Chief Executive Officer

Chief Financial Officer

President, Salix Pharmaceuticals

View full Bausch Health profile